Request for Covid-19 Impact Assessment of this Report
The United States GnRH Receptor Antagonists market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global GnRH Receptor Antagonists market, reaching US$ million by the year 2028. As for the Europe GnRH Receptor Antagonists landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main GnRH Receptor Antagonists players cover AbbVie, Takeda, Astellas, and Kissei, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of GnRH Receptor Antagonists market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Peptides
Small Molecules
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Prostate Cancer
Endometriosis
Uterine Fibroids
Female Infertility
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AbbVie
Takeda
Astellas
Kissei
Veru Inc
Myovant Sciences
AstraZeneca
Ferring Pharmaceuticals
Jiangsu Hengrui Medicine Co
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global GnRH Receptor Antagonists Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for GnRH Receptor Antagonists by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for GnRH Receptor Antagonists by Country/Region, 2017, 2022 & 2028
2.2 GnRH Receptor Antagonists Segment by Type
2.2.1 Peptides
2.2.2 Small Molecules
2.3 GnRH Receptor Antagonists Sales by Type
2.3.1 Global GnRH Receptor Antagonists Sales Market Share by Type (2017-2022)
2.3.2 Global GnRH Receptor Antagonists Revenue and Market Share by Type (2017-2022)
2.3.3 Global GnRH Receptor Antagonists Sale Price by Type (2017-2022)
2.4 GnRH Receptor Antagonists Segment by Application
2.4.1 Prostate Cancer
2.4.2 Endometriosis
2.4.3 Uterine Fibroids
2.4.4 Female Infertility
2.4.5 Others
2.5 GnRH Receptor Antagonists Sales by Application
2.5.1 Global GnRH Receptor Antagonists Sale Market Share by Application (2017-2022)
2.5.2 Global GnRH Receptor Antagonists Revenue and Market Share by Application (2017-2022)
2.5.3 Global GnRH Receptor Antagonists Sale Price by Application (2017-2022)
3 Global GnRH Receptor Antagonists by Company
3.1 Global GnRH Receptor Antagonists Breakdown Data by Company
3.1.1 Global GnRH Receptor Antagonists Annual Sales by Company (2020-2022)
3.1.2 Global GnRH Receptor Antagonists Sales Market Share by Company (2020-2022)
3.2 Global GnRH Receptor Antagonists Annual Revenue by Company (2020-2022)
3.2.1 Global GnRH Receptor Antagonists Revenue by Company (2020-2022)
3.2.2 Global GnRH Receptor Antagonists Revenue Market Share by Company (2020-2022)
3.3 Global GnRH Receptor Antagonists Sale Price by Company
3.4 Key Manufacturers GnRH Receptor Antagonists Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers GnRH Receptor Antagonists Product Location Distribution
3.4.2 Players GnRH Receptor Antagonists Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for GnRH Receptor Antagonists by Geographic Region
4.1 World Historic GnRH Receptor Antagonists Market Size by Geographic Region (2017-2022)
4.1.1 Global GnRH Receptor Antagonists Annual Sales by Geographic Region (2017-2022)
4.1.2 Global GnRH Receptor Antagonists Annual Revenue by Geographic Region
4.2 World Historic GnRH Receptor Antagonists Market Size by Country/Region (2017-2022)
4.2.1 Global GnRH Receptor Antagonists Annual Sales by Country/Region (2017-2022)
4.2.2 Global GnRH Receptor Antagonists Annual Revenue by Country/Region
4.3 Americas GnRH Receptor Antagonists Sales Growth
4.4 APAC GnRH Receptor Antagonists Sales Growth
4.5 Europe GnRH Receptor Antagonists Sales Growth
4.6 Middle East & Africa GnRH Receptor Antagonists Sales Growth
5 Americas
5.1 Americas GnRH Receptor Antagonists Sales by Country
5.1.1 Americas GnRH Receptor Antagonists Sales by Country (2017-2022)
5.1.2 Americas GnRH Receptor Antagonists Revenue by Country (2017-2022)
5.2 Americas GnRH Receptor Antagonists Sales by Type
5.3 Americas GnRH Receptor Antagonists Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC GnRH Receptor Antagonists Sales by Region
6.1.1 APAC GnRH Receptor Antagonists Sales by Region (2017-2022)
6.1.2 APAC GnRH Receptor Antagonists Revenue by Region (2017-2022)
6.2 APAC GnRH Receptor Antagonists Sales by Type
6.3 APAC GnRH Receptor Antagonists Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe GnRH Receptor Antagonists by Country
7.1.1 Europe GnRH Receptor Antagonists Sales by Country (2017-2022)
7.1.2 Europe GnRH Receptor Antagonists Revenue by Country (2017-2022)
7.2 Europe GnRH Receptor Antagonists Sales by Type
7.3 Europe GnRH Receptor Antagonists Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa GnRH Receptor Antagonists by Country
8.1.1 Middle East & Africa GnRH Receptor Antagonists Sales by Country (2017-2022)
8.1.2 Middle East & Africa GnRH Receptor Antagonists Revenue by Country (2017-2022)
8.2 Middle East & Africa GnRH Receptor Antagonists Sales by Type
8.3 Middle East & Africa GnRH Receptor Antagonists Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of GnRH Receptor Antagonists
10.3 Manufacturing Process Analysis of GnRH Receptor Antagonists
10.4 Industry Chain Structure of GnRH Receptor Antagonists
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 GnRH Receptor Antagonists Distributors
11.3 GnRH Receptor Antagonists Customer
12 World Forecast Review for GnRH Receptor Antagonists by Geographic Region
12.1 Global GnRH Receptor Antagonists Market Size Forecast by Region
12.1.1 Global GnRH Receptor Antagonists Forecast by Region (2023-2028)
12.1.2 Global GnRH Receptor Antagonists Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global GnRH Receptor Antagonists Forecast by Type
12.7 Global GnRH Receptor Antagonists Forecast by Application
13 Key Players Analysis
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie GnRH Receptor Antagonists Product Offered
13.1.3 AbbVie GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Takeda
13.2.1 Takeda Company Information
13.2.2 Takeda GnRH Receptor Antagonists Product Offered
13.2.3 Takeda GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Takeda Main Business Overview
13.2.5 Takeda Latest Developments
13.3 Astellas
13.3.1 Astellas Company Information
13.3.2 Astellas GnRH Receptor Antagonists Product Offered
13.3.3 Astellas GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Astellas Main Business Overview
13.3.5 Astellas Latest Developments
13.4 Kissei
13.4.1 Kissei Company Information
13.4.2 Kissei GnRH Receptor Antagonists Product Offered
13.4.3 Kissei GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Kissei Main Business Overview
13.4.5 Kissei Latest Developments
13.5 Veru Inc
13.5.1 Veru Inc Company Information
13.5.2 Veru Inc GnRH Receptor Antagonists Product Offered
13.5.3 Veru Inc GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Veru Inc Main Business Overview
13.5.5 Veru Inc Latest Developments
13.6 Myovant Sciences
13.6.1 Myovant Sciences Company Information
13.6.2 Myovant Sciences GnRH Receptor Antagonists Product Offered
13.6.3 Myovant Sciences GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Myovant Sciences Main Business Overview
13.6.5 Myovant Sciences Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca GnRH Receptor Antagonists Product Offered
13.7.3 AstraZeneca GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Ferring Pharmaceuticals
13.8.1 Ferring Pharmaceuticals Company Information
13.8.2 Ferring Pharmaceuticals GnRH Receptor Antagonists Product Offered
13.8.3 Ferring Pharmaceuticals GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Ferring Pharmaceuticals Main Business Overview
13.8.5 Ferring Pharmaceuticals Latest Developments
13.9 Jiangsu Hengrui Medicine Co
13.9.1 Jiangsu Hengrui Medicine Co Company Information
13.9.2 Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Product Offered
13.9.3 Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangsu Hengrui Medicine Co Main Business Overview
13.9.5 Jiangsu Hengrui Medicine Co Latest Developments
14 Research Findings and Conclusion
Table 1. GnRH Receptor Antagonists Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. GnRH Receptor Antagonists Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Peptides
Table 4. Major Players of Small Molecules
Table 5. Global GnRH Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 6. Global GnRH Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 7. Global GnRH Receptor Antagonists Revenue by Type (2017-2022) & ($ million)
Table 8. Global GnRH Receptor Antagonists Revenue Market Share by Type (2017-2022)
Table 9. Global GnRH Receptor Antagonists Sale Price by Type (2017-2022) & (USD/Unit)
Table 10. Global GnRH Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 11. Global GnRH Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 12. Global GnRH Receptor Antagonists Revenue by Application (2017-2022)
Table 13. Global GnRH Receptor Antagonists Revenue Market Share by Application (2017-2022)
Table 14. Global GnRH Receptor Antagonists Sale Price by Application (2017-2022) & (USD/Unit)
Table 15. Global GnRH Receptor Antagonists Sales by Company (2020-2022) & (K Units)
Table 16. Global GnRH Receptor Antagonists Sales Market Share by Company (2020-2022)
Table 17. Global GnRH Receptor Antagonists Revenue by Company (2020-2022) ($ Millions)
Table 18. Global GnRH Receptor Antagonists Revenue Market Share by Company (2020-2022)
Table 19. Global GnRH Receptor Antagonists Sale Price by Company (2020-2022) & (USD/Unit)
Table 20. Key Manufacturers GnRH Receptor Antagonists Producing Area Distribution and Sales Area
Table 21. Players GnRH Receptor Antagonists Products Offered
Table 22. GnRH Receptor Antagonists Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global GnRH Receptor Antagonists Sales by Geographic Region (2017-2022) & (K Units)
Table 26. Global GnRH Receptor Antagonists Sales Market Share Geographic Region (2017-2022)
Table 27. Global GnRH Receptor Antagonists Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global GnRH Receptor Antagonists Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global GnRH Receptor Antagonists Sales by Country/Region (2017-2022) & (K Units)
Table 30. Global GnRH Receptor Antagonists Sales Market Share by Country/Region (2017-2022)
Table 31. Global GnRH Receptor Antagonists Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global GnRH Receptor Antagonists Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas GnRH Receptor Antagonists Sales by Country (2017-2022) & (K Units)
Table 34. Americas GnRH Receptor Antagonists Sales Market Share by Country (2017-2022)
Table 35. Americas GnRH Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas GnRH Receptor Antagonists Revenue Market Share by Country (2017-2022)
Table 37. Americas GnRH Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 38. Americas GnRH Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 39. Americas GnRH Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 40. Americas GnRH Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 41. APAC GnRH Receptor Antagonists Sales by Region (2017-2022) & (K Units)
Table 42. APAC GnRH Receptor Antagonists Sales Market Share by Region (2017-2022)
Table 43. APAC GnRH Receptor Antagonists Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC GnRH Receptor Antagonists Revenue Market Share by Region (2017-2022)
Table 45. APAC GnRH Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 46. APAC GnRH Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 47. APAC GnRH Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 48. APAC GnRH Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 49. Europe GnRH Receptor Antagonists Sales by Country (2017-2022) & (K Units)
Table 50. Europe GnRH Receptor Antagonists Sales Market Share by Country (2017-2022)
Table 51. Europe GnRH Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe GnRH Receptor Antagonists Revenue Market Share by Country (2017-2022)
Table 53. Europe GnRH Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 54. Europe GnRH Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 55. Europe GnRH Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 56. Europe GnRH Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa GnRH Receptor Antagonists Sales by Country (2017-2022) & (K Units)
Table 58. Middle East & Africa GnRH Receptor Antagonists Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa GnRH Receptor Antagonists Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa GnRH Receptor Antagonists Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa GnRH Receptor Antagonists Sales by Type (2017-2022) & (K Units)
Table 62. Middle East & Africa GnRH Receptor Antagonists Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa GnRH Receptor Antagonists Sales by Application (2017-2022) & (K Units)
Table 64. Middle East & Africa GnRH Receptor Antagonists Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of GnRH Receptor Antagonists
Table 66. Key Market Challenges & Risks of GnRH Receptor Antagonists
Table 67. Key Industry Trends of GnRH Receptor Antagonists
Table 68. GnRH Receptor Antagonists Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. GnRH Receptor Antagonists Distributors List
Table 71. GnRH Receptor Antagonists Customer List
Table 72. Global GnRH Receptor Antagonists Sales Forecast by Region (2023-2028) & (K Units)
Table 73. Global GnRH Receptor Antagonists Sales Market Forecast by Region
Table 74. Global GnRH Receptor Antagonists Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global GnRH Receptor Antagonists Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas GnRH Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)
Table 77. Americas GnRH Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC GnRH Receptor Antagonists Sales Forecast by Region (2023-2028) & (K Units)
Table 79. APAC GnRH Receptor Antagonists Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe GnRH Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Europe GnRH Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa GnRH Receptor Antagonists Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Middle East & Africa GnRH Receptor Antagonists Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global GnRH Receptor Antagonists Sales Forecast by Type (2023-2028) & (K Units)
Table 85. Global GnRH Receptor Antagonists Sales Market Share Forecast by Type (2023-2028)
Table 86. Global GnRH Receptor Antagonists Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global GnRH Receptor Antagonists Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global GnRH Receptor Antagonists Sales Forecast by Application (2023-2028) & (K Units)
Table 89. Global GnRH Receptor Antagonists Sales Market Share Forecast by Application (2023-2028)
Table 90. Global GnRH Receptor Antagonists Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global GnRH Receptor Antagonists Revenue Market Share Forecast by Application (2023-2028)
Table 92. AbbVie Basic Information, GnRH Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 93. AbbVie GnRH Receptor Antagonists Product Offered
Table 94. AbbVie GnRH Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 95. AbbVie Main Business
Table 96. AbbVie Latest Developments
Table 97. Takeda Basic Information, GnRH Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 98. Takeda GnRH Receptor Antagonists Product Offered
Table 99. Takeda GnRH Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 100. Takeda Main Business
Table 101. Takeda Latest Developments
Table 102. Astellas Basic Information, GnRH Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 103. Astellas GnRH Receptor Antagonists Product Offered
Table 104. Astellas GnRH Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 105. Astellas Main Business
Table 106. Astellas Latest Developments
Table 107. Kissei Basic Information, GnRH Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 108. Kissei GnRH Receptor Antagonists Product Offered
Table 109. Kissei GnRH Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 110. Kissei Main Business
Table 111. Kissei Latest Developments
Table 112. Veru Inc Basic Information, GnRH Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 113. Veru Inc GnRH Receptor Antagonists Product Offered
Table 114. Veru Inc GnRH Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 115. Veru Inc Main Business
Table 116. Veru Inc Latest Developments
Table 117. Myovant Sciences Basic Information, GnRH Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 118. Myovant Sciences GnRH Receptor Antagonists Product Offered
Table 119. Myovant Sciences GnRH Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 120. Myovant Sciences Main Business
Table 121. Myovant Sciences Latest Developments
Table 122. AstraZeneca Basic Information, GnRH Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 123. AstraZeneca GnRH Receptor Antagonists Product Offered
Table 124. AstraZeneca GnRH Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 125. AstraZeneca Main Business
Table 126. AstraZeneca Latest Developments
Table 127. Ferring Pharmaceuticals Basic Information, GnRH Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 128. Ferring Pharmaceuticals GnRH Receptor Antagonists Product Offered
Table 129. Ferring Pharmaceuticals GnRH Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 130. Ferring Pharmaceuticals Main Business
Table 131. Ferring Pharmaceuticals Latest Developments
Table 132. Jiangsu Hengrui Medicine Co Basic Information, GnRH Receptor Antagonists Manufacturing Base, Sales Area and Its Competitors
Table 133. Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Product Offered
Table 134. Jiangsu Hengrui Medicine Co GnRH Receptor Antagonists Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 135. Jiangsu Hengrui Medicine Co Main Business
Table 136. Jiangsu Hengrui Medicine Co Latest Developments
List of Figures
Figure 1. Picture of GnRH Receptor Antagonists
Figure 2. GnRH Receptor Antagonists Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global GnRH Receptor Antagonists Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global GnRH Receptor Antagonists Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. GnRH Receptor Antagonists Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Peptides
Figure 10. Product Picture of Small Molecules
Figure 11. Global GnRH Receptor Antagonists Sales Market Share by Type in 2021
Figure 12. Global GnRH Receptor Antagonists Revenue Market Share by Type (2017-2022)
Figure 13. GnRH Receptor Antagonists Consumed in Prostate Cancer
Figure 14. Global GnRH Receptor Antagonists Market: Prostate Cancer (2017-2022) & (K Units)
Figure 15. GnRH Receptor Antagonists Consumed in Endometriosis
Figure 16. Global GnRH Receptor Antagonists Market: Endometriosis (2017-2022) & (K Units)
Figure 17. GnRH Receptor Antagonists Consumed in Uterine Fibroids
Figure 18. Global GnRH Receptor Antagonists Market: Uterine Fibroids (2017-2022) & (K Units)
Figure 19. GnRH Receptor Antagonists Consumed in Female Infertility
Figure 20. Global GnRH Receptor Antagonists Market: Female Infertility (2017-2022) & (K Units)
Figure 21. GnRH Receptor Antagonists Consumed in Others
Figure 22. Global GnRH Receptor Antagonists Market: Others (2017-2022) & (K Units)
Figure 23. Global GnRH Receptor Antagonists Sales Market Share by Application (2017-2022)
Figure 24. Global GnRH Receptor Antagonists Revenue Market Share by Application in 2021
Figure 25. GnRH Receptor Antagonists Revenue Market by Company in 2021 ($ Million)
Figure 26. Global GnRH Receptor Antagonists Revenue Market Share by Company in 2021
Figure 27. Global GnRH Receptor Antagonists Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global GnRH Receptor Antagonists Revenue Market Share by Geographic Region in 2021
Figure 29. Global GnRH Receptor Antagonists Sales Market Share by Region (2017-2022)
Figure 30. Global GnRH Receptor Antagonists Revenue Market Share by Country/Region in 2021
Figure 31. Americas GnRH Receptor Antagonists Sales 2017-2022 (K Units)
Figure 32. Americas GnRH Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 33. APAC GnRH Receptor Antagonists Sales 2017-2022 (K Units)
Figure 34. APAC GnRH Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 35. Europe GnRH Receptor Antagonists Sales 2017-2022 (K Units)
Figure 36. Europe GnRH Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa GnRH Receptor Antagonists Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa GnRH Receptor Antagonists Revenue 2017-2022 ($ Millions)
Figure 39. Americas GnRH Receptor Antagonists Sales Market Share by Country in 2021
Figure 40. Americas GnRH Receptor Antagonists Revenue Market Share by Country in 2021
Figure 41. United States GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC GnRH Receptor Antagonists Sales Market Share by Region in 2021
Figure 46. APAC GnRH Receptor Antagonists Revenue Market Share by Regions in 2021
Figure 47. China GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 51. India GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe GnRH Receptor Antagonists Sales Market Share by Country in 2021
Figure 54. Europe GnRH Receptor Antagonists Revenue Market Share by Country in 2021
Figure 55. Germany GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 56. France GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa GnRH Receptor Antagonists Sales Market Share by Country in 2021
Figure 61. Middle East & Africa GnRH Receptor Antagonists Revenue Market Share by Country in 2021
Figure 62. Egypt GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country GnRH Receptor Antagonists Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of GnRH Receptor Antagonists in 2021
Figure 68. Manufacturing Process Analysis of GnRH Receptor Antagonists
Figure 69. Industry Chain Structure of GnRH Receptor Antagonists
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...